Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine

Infantile hepatic hemangiomas (IHH), particularly of the diffuse subtype can, in severe cases, be associated with hepatic and cardiac failure, compartment syndrome and consumptive hypothyroidism. Early recognition and treatment of these pathologies is paramount in order to minimise the risk of long-term sequelae. We report an interesting case of a female infant who presented with systemic compromise, in the absence of large or obvious cutaneous infantile hemangiomas. Imaging identified innumerable hepatic hemangiomas, consistent with diffuse infantile hepatic hemangiomatosis. Subsequent to this, thyroid function tests confirmed an associated but comparatively rare form of hypothyroidism, known as consumptive hypothyroidism. Following joint consultation with dermatology and endocrinology she was promptly treated with oral propranolol and levothyroxine, with subsequent improvement in her clinical parameters. This case reiterates the importance of aggressive investigation and management of consumptive hypothyroidism in any infant diagnosed with IHH, particularly when there is systemic compromise. We advocate propranolol as a single first line treatment for IHH, supported by thyroid replacement when appropriate.

___

Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008;25:168-173.

Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. New Engl J Med 1999;341:173-181.

Chen XD, Ma G, Chen H, Ye XX, Jin YB, Lin XX. Maternal and perinatal risk factors for infantile hemangioma: A case-control study. Pediatr Dermatol 2013;30:457-461. Epub 2012 Dec 26

Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement G, Mulliken JB, Fishman SJ. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42:62-68.

Horii KA, Drolet BA, Frieden IJ, Baselga E, Chamlin SL, Haggstrom AN, Holland KE, Mancini AJ, McCuaig CC, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Garzon MC; Hemangioma Investigator Group. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 2011;28:245-253. Epub 2011 Apr 26

Yeh I, Bruckner A, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol 2011;28:267-275. Epub 2011 Apr 26

Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, Fishman SJ, Larsen PR. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. New Eng J Med 2000;343:185-189.

Cho YH, Taplin C, Mansour A, Howman-Giles R, Hardwick R, Lord D, Howard NJ. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic hemangiomas. Curr Opin in Pediatr 2008;20:213-215.

Mouat F, Evans HM, Cutfield WS, Hofman PL, Jefferies C. Massive hepatic hemangioendothelioma and consumptive hypothyroidism. J Pediatr Endocrinol Metab 2008;21:701-703.

Bessho K, Etani Y, Ichimori H, Miyoshi Y, Namba N, Yoneda A, Ooue T, Chihara T, Morii E, Aoki T, Murakami M, Mushiake S, Ozono K. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 2010;169:215-221. Epub 2009 Jun 23

Fisher DA. Clinical review 19: Management of congenital hypothyroidism. J Clin Endocr Metab 1991;72:523-529.

Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics 2011;127:772-776. Epub 2011 Feb 28

Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Letter to the editor: massive response of severe infantile hepatic hemangioma to propranolol. Pediatric Blood & Cancer 2010;54:176.

Mazereeuw-Hautier J, Hoeger P, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Leaute-Labreze C, Labenne M, Vabres P, Rössler J, Bodemer C. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Paediatr 2010;157:340-342. Epub 2010 May 20

Mhanna A, Franklin WH, Mancini AJ. Hepatic infantile hemangiomas treated with oral propranolol -- a case series. Pediatr Dermatol 2011;28:39-45. Epub 2011 Jan 25.

Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009;44:125-133.

Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004;35:200-209.

North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC Jr. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137: 559-570.

Emir S, Ekici F, Ikiz MA, Vidinlisan S. The association of consumptive hypothyroidism secondary to hepatic hemangioma and severe heart failure in infancy. Turk Pediatri Ars 2016;51:52-56.

Al Tasseh F, El-Khansa M, Abd O, Khalek AA, El-Rifai N. Diffuse hepatic hemangioma with single cutaneous hemangioma: an alerting occurrence. Clin Case Rep 2017;5:887-890.

Konrad D, Ellis G, Perlman K. Spontaneous regression of severe acquired infantile hypothyroidism with multiple liver hemangiomas. Pediatrics 2003;112:1424-1426.

Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. New Eng J Med 2008;358:2649-2651.

___

Journal of Clinical Research in Pediatric Endocrinology
  • ISSN: 1308-5727
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2008

9b7.1b

Sayıdaki Diğer Makaleler

Investigation of MKRN3 Mutation in Patients with Familial Central Precocious Puberty

ZEHRA AYCAN, ŞENAY SAVAŞ ERDEVE, SEMRA ÇETİNKAYA, Erdal KURNAZ, Melikşah KESKİN, Nursel MURATOĞLU ŞAHİN, Elvan BAYRAMOĞLU, Gülay CEYLANER

Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?

EMİNE ÇAMTOSUN, ZEYNEP ŞIKLAR, MERİH BERBEROĞLU

The Importance of Gestation-Adjusted Birthweight Centile in Assessment of Fetal Growth in Metabolic Conditions

Caroline OVADİA, Hanns-Ulrich MARSCHALL, Catherine WİLLİAMSON

A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations

Aslı Derya KARDELEN, Güven TOKSOY, FİRDEVS BAŞ, Zehra Yavaş ABALI, Genco GENÇAY, ŞÜKRAN POYRAZOĞLU, Rüveyde BUNDAK, Umut ALTUNOĞLU, Şahin AVCI, Adam NAJAFLI, ZEHRA OYA UYGUNER, BİRSEN KARAMAN, SEHER BAŞARAN, FATMA FEYZA DARENDELİLER

Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty

Nursel MURATOĞLU ŞAHİN, ASİYE UĞRAŞ DİKMEN, SEMRA ÇETİNKAYA, ZEHRA AYCAN

Severe Early Onset Obesity due to a Novel Missense Mutation in Exon 3 of the Leptin Gene in an Infant from Northwest India

Devi DAYAL, Keerthivasan SEETHARAMAN, Inusha PANİGRAHİ, Balasubramaniyan MUTHUVEL, Ashish AGARWAL

A Synopsis of Current Practice in the Diagnosis and Management of Patients with Turner Syndrome in Turkey: A Survey of 18 Pediatric Endocrinology Centers

Ahmet UÇAR, AYHAN ABACI, MUSTAFA ÖZGÜR PİRGON, BUMİN NURİ DÜNDAR, FİLİZ TÜTÜNCÜLER KÖKENLİ, GÖNÜL ÇATLI, AHMET ANIK, Aylin KILINÇ UĞURLU, Atilla BÜYÜKGEBİZ

Parental Perception of Terminology of Disorders of Sex Development in Western Turkey

Sibel TİRYAKİ, ALİ TEKİN, İSMAİL YAĞMUR, SAMİM ÖZEN, Burcu ÖZBARAN, RUHSAR DAMLA GÖKŞEN ŞİMŞEK, ŞÜKRAN DARCAN, İBRAHİM ULMAN, Ali AVANOĞLU

Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life

FİLİZ MİNE ÇİZMECİOĞLU, Jeremy Huw JONES, Wendy Forsyth PATERSON, Sakina KHERRA, Mariam KOURİME, Ruth MCGOWAN, M. Guftar SHAİKH, Malcolm DONALDSON

A Novel Variant c.97C>T of the Growth Hormone Releasing Hormone Receptor Gene Causes Isolated Growth Hormone Deficiency Type Ib

Assimina GALLİ-TSİNOPOULOU, Eleni P. KOTANİDOU, Aggeliki N. KLEİSARCHAKİ, Rivka KAULİ, Zvi LARON